News

With this, in total the company has received approximately $53m in its Series B financing from its investors like Novartis Venture Funds, Sofinnova Ventures, ARCH Venture Partners, CMEA

Metamark’s quantitative diagnostic approach detects and account for small regions of molecular cancer cells within an otherwise indolent tumor. Metamark has also developed prognostic and predictive assays portfolio

The company intends to recruit around 350 patients at clinical sites of Western Europe and North America. The primary endpoint of the trial is to establish the effect

The two companies intend to develop certain compounds through technology transfer and out-licensing deals with venture funding from Pfizer’s pipeline. Under the terms of the MoU, the two

As per the terms of the agreement, RxMD will use its drug development expertise for enhancing GRI’s line of drugs. GRI CEO Marc Hertz said they now have

CIP-TRAMADOL ER, an extended-release formulation of tramadol, is indicated for the treatment of moderate to moderately severe chronic pain in adults. As per the terms of the agreement,

The patented synthetic cell membranes are tucked into a polymer matrix outside a cellular environment. The synthetic cell membranes, which are essentially membrane proteins, create a platform for

As per the terms of the agreement, Sanofi expects to offer around 80,000 chemical compounds to Carl Nathan’s laboratory at Weill Cornellto where they will screen the compounds

The alliance creates a drug discovery bridge between UCB and Harvard scientists to continue their research that holds potential for the development of new therapeutic modalities in clinical